{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:22:06Z","timestamp":1787862126856,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUST-1-CPH-2024-1748"],"award-info":[{"award-number":["QUST-1-CPH-2024-1748"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jiph.2026.103303","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:55:49Z","timestamp":1783007749000},"page":"103303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study"],"prefix":"10.1016","volume":"19","author":[{"given":"Duha Samer","family":"Akasheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour Abdallah","family":"Abu Asfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Elajez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Zeyad","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5141-6861","authenticated-orcid":false,"given":"Masautso","family":"Chaponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Ezzeldin Mohd.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-2877","authenticated-orcid":false,"given":"Usman","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.jiph.2026.103303_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2026.103303_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jgar.2021.02.033","article-title":"Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade","volume":"25","author":"Sleiman","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jiph.2026.103303_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/medsci6010001","article-title":"Carbapenem resistance: a review","volume":"6","author":"Codjoe","year":"2017","journal-title":"Med Sci"},{"issue":"ement_7","key":"10.1016\/j.jiph.2026.103303_bib4","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103303_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","article-title":"Therapeutic options for carbapenem-resistant Enterobacteriaceae infections","volume":"8","author":"Trecarichi","year":"2017","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.jiph.2026.103303_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/tropicalmed7120415","article-title":"Treatments and predictors of mortality for carbapenem-resistant Gram-negative bacilli infections in Malaysia: a retrospective cohort study","volume":"7","author":"Abubakar","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103303_bib7","first-page":"1","article-title":"Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies","volume":"5","author":"Zhang","year":"2016","journal-title":"Emerg Microbes & Infect"},{"issue":"5","key":"10.1016\/j.jiph.2026.103303_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jmii.2016.08.022","article-title":"Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: a retrospective propensity-matched case control study","volume":"51","author":"Ting","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.jiph.2026.103303_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijantimicag.2017.12.012","article-title":"High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region","volume":"51","author":"Vargas-Alzate","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2026.103303_bib10","first-page":"687","article-title":"Identification of novel biomarkers for predicting kidney injury due to drugs using \u201comic\u201d strategies","author":"Awdishu","year":"2020","journal-title":"Pharm Pers Med"},{"issue":"4","key":"10.1016\/j.jiph.2026.103303_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jiph.2026.103303_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmi.2020.12.009","article-title":"Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins","volume":"27","author":"Wagenlehner","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiph.2026.103303_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2018.11.008","article-title":"Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies","volume":"94","author":"Oliota","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.jiph.2026.103303_bib14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/antibiotics12071183","article-title":"The prevalence and risk factors of acute kidney injury during colistin therapy: a retrospective cohort study from lebanon","volume":"12","author":"Moghnieh","year":"2023","journal-title":"Antibiotics"},{"issue":"11","key":"10.1016\/j.jiph.2026.103303_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/antibiotics11111569","article-title":"Incidence and risk factors of colistin-induced nephrotoxicity associated with the international consensus guidelines for the optimal use of the polymyxins: a retrospective study in a tertiary care hospital, Saudi Arabia","volume":"11","author":"Alotaibi","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jiph.2026.103303_bib16","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2147\/IDR.S409964","article-title":"Comprehensive assessment of colistin induced nephrotoxicity: incidence, risk factors and time course","author":"Rabi","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.jiph.2026.103303_bib17","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.jiph.2026.103303_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol & Ther"},{"issue":"3","key":"10.1016\/j.jiph.2026.103303_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105889","article-title":"Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis","volume":"55","author":"Chien","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jiph.2026.103303_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.06980717","article-title":"Attributable risk and time course of colistin-associated acute kidney injury","volume":"13","author":"Miano","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.jiph.2026.103303_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/17512433.2021.1933436","article-title":"Prevention of colistin induced nephrotoxicity: a review of preclinical and clinical data","volume":"14","author":"Jafari","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jiph.2026.103303_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcrc.2017.11.022","article-title":"Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: a comparative cohort study","volume":"44","author":"Meraz-Mu\u00f1oz","year":"2018","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.jiph.2026.103303_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/0886022X.2020.1795878","article-title":"Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit","volume":"42","author":"Gunay","year":"2020","journal-title":"Ren Fail"},{"issue":"2","key":"10.1016\/j.jiph.2026.103303_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11096-018-0607-y","article-title":"Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium","volume":"40","author":"Hassan","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.jiph.2026.103303_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.xkme.2021.02.007","article-title":"Sepsis-associated acute kidney disease and long-term kidney outcomes","volume":"3","author":"Flannery","year":"2021","journal-title":"Kidney Med"},{"issue":"2","key":"10.1016\/j.jiph.2026.103303_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccc.2020.11.010","article-title":"Sepsis-associated acute kidney injury","volume":"37","author":"Manrique-Caballero","year":"2021","journal-title":"Crit Care Clin"},{"issue":"9","key":"10.1016\/j.jiph.2026.103303_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2026.103303_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/antibiotics9080485","article-title":"Impact of colistin dosing on the incidence of nephrotoxicity in a tertiary care hospital in Saudi Arabia","volume":"9","author":"Almutairy","year":"2020","journal-title":"Antibiotics"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:47:26Z","timestamp":1787860046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1876034126001759"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103303","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103303"}}